NCCN 2012 Congress Webinar Series: Skin Cancers™: Treatment of Metastatic Melanoma

August 2, 2012

This webinar series is designed to provide an in-depth analysis of the evidence and clinical decision-making that led to the development of the NCCN Guidelines® for Melanoma and Non-Melanoma Skin Cancers. Participants will learn how to implement the NCCN Guidelines recommendations into their practice and gain a clear understanding of the most up-to-date treatment recommendations for these cancers. As research continues in these areas and new information emerges, it is critical that clinicians are kept up-to-date and informed. This series will communicate the NCCN Guidelines in a direct and interactive way to community oncologists and other clinical professionals.

Target Audience

This educational program is designed to meet the educational needs of oncologists, pathologists, nurses, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Discuss the role of ipilimumab immunotherapy in metastatic disease and monitoring of side effects
  • Describe the specific indication for vemurafenib and the necessary dermatologic surveillance

 

Additional information
Supporters: 

This activity is supported by educational grants from:

  • Bristol-Myers Squibb
  • Genentech

The National Comprehensive Cancer Network® (NCCN®) appreciates that supporting companies recognize NCCN’s need for autonomy in the development of the content of NCCN resources. All NCCN content is produced completely independently.

Course summary
Available credit: 
  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician
Course opens: 
08/02/2012
Course expires: 
10/17/2012
Event starts: 
08/02/2012 - 1:30pm EDT
Event ends: 
08/02/2012 - 2:30pm EDT
Cost:
$0.00

Anthony J. Olszanski, MD
Fox Chase Cancer Center

Available Credit

  • 1.00 Participation
  • 1.00 Nurse
  • 1.00 Pharmacist
  • 1.00 Physician

Price

Cost:
$0.00
Please login or register to take this course.